Oxcarbazepine
NDC 59651-785, Oxcarbazepine, tablet, film coated, extended release, from Aurobindo Pharma Limited.
- Product NDC
- 59651-785
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219241
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-785 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE150 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-785-01 | 59651078501 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-785-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/21caded0-2ed7-4f7d-9856-27ef7c1a47c8
Use it
Look up 59651-785 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-785 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-785. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.